Search API
Novavax, Inc. recently announced that Nuvaxovid™ had been recommended for full Marketing Authorization (MA) for use as a primary series in individuals aged 12 and older and as a booster in individuals aged 18 and older for the prevention of COVID-19 in the European Union (EU) following a positive opinion issued by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency.
The European Commission is expected to make a final decision on the MA.
Novavax COVID-19 vaccine Nuvaxovid was the first protein-based vaccine engineered from the genetic sequence of the SARS-CoV-2 beta coronavirus.
"The positive CHMP Opinion for full Marketing Authorization for our COVID vaccine brings us one step closer to full authorization and will provide an approval pathway for an updated vaccine in time for the fall," said John C. Jacobs, President and Chief Executive Officer, Novavax, in a press release on May 25, 2023.
In the EU, Nuvaxovid has been conditionally authorized as a two-dose primary series in adults and adolescents and as a booster dose in adults.
Novavax's COVID vaccine is authorized for use in more than 40 markets worldwide.
The trade name Nuvaxovid has not yet been approved by the U.S. Food and Drug Administration.
Novavax's vaccine is known as CovoVax™ and NVX-CoV2373 globally.
The Pan American Health Organization (PAHO) recently reported Respiratory Syncytial Virus (RSV) cases in Latin America and the Caribbean for Epidemiological Week #18 of 2023.
As of May 24, 2023, the PAHO confirmed RSV activity has remained low throughout most of the Americas.
However, in Brazil and Southern Cone, RSV activity, after showing an increase in recent weeks, a decreasing trend has been observed.
In the U.S., Florida’s RSV season is longer than the rest of the nation and has distinct regional patterns. However, as of late May 2023, Florida has not reported an RSV outbreak.
RSV is a common respiratory virus that usually causes mild, cold-like symptoms.
However, according to the Florida Department of Health, young children and older adults, especially those with certain underlying health conditions, are at higher risk for severe illness from RSV.
RSV is a vaccine-preventable disease in older adults, and RSV monoclonal antibody therapies were approved for infants in 2023.
The U.S. Centers for Disease Control and Prevention recently released preliminary Tuberculosis (TB) cases data that the U.S. is also experiencing a disease resurgence.
The CDC reported that TB disease cases increased by 5% in 2022 to 8,300 cases.
TB cases have recently increased in California, New York, and Texas.
Healthcare providers and communities disproportionately affected by TB are recommended to.... Think. Test. Treat TB.
According to the WHO 2022 Global TB Report, an estimated 1.6 million people died from TB, an increase of 4.5% in one year.
As of May 29, 2023, the 100-year-old Bacille Calmette-Guérin (BCG) vaccine is not widely used in the U.S. However, it is often given to infants and small children in other countries where TB is common.
There are over ten versions of the BCG vaccine used globally.
The U.S. CDC reissued it's Alert - Level 2, Practice Enhanced Precautions travel advisory regarding U.S. residents returning from Matamoros, Mexico, who were diagnosed with suspected fungal meningitis infections that have led to severe illness and death.
As of May 26, 2023, the CDC stated people should cancel any elective procedure that involves an epidural injection of an anesthetic in Matamoros, Mexico until there is evidence that there is no longer a risk for infection at these clinics.
Furthermore, all medical and surgical procedures carry some risk, and complications can occur regardless of where treatment is received.
The risk of complications depends on the destination, the facility where the procedure is being performed, and whether you are in good physical and psychological condition for the procedure(s).
And learn how to minimize risks if you are considering traveling to another country for medical care, says the CDC.
After a lull of nearly two months throughout the country, the resurgence of avian influenza (bird flu) in France's South West in May 2023 has triggered an immediate response.
Reuters reported on May 26, 2023, France announced an avian influenza (bird flu) vaccination program would launch in late 2023.
Marc Fesneau, Minister of Agriculture and Food Sovereignty, called on May 22, 2023, for all avenues to be explored to improve the fight against highly pathogenic avian influenza (HPAI), foremost among which is vaccination.
On April 6, 2023, France launched a tender for 80 million doses of bird flu vaccines.
Temporary authorization for use has recently been submitted for vaccines for poultry species currently being assessed by the French Agency for Veterinary Medicinal Products and the European Medicines Agency.
To date, only one vaccine for chickens (Gallus gallus species) has marketing authorization in France (2006).
In the U.S., the Department of Agriculture's Agricultural Research Service recently confirmed they are testing several bird flu vaccine candidates. On May 16, 2023, the emergency use of an HPAI vaccine candidate to prevent additional deaths of California Condors.
Additional avian and human bird flu vaccine development news as of May 27, 2023, is posted by Precision Vaccinations.
According to Japan's National Institute of Infectious Diseases reported on May 14, 2023, the number of syphilis patients totaled 5,164 in 2023. The data for the same period in 2022 was 3,630.
The IDWR Surveillance Data Table week #19 confirmed Tokyo had the most cases at 1,332, followed by Osaka with 699 cases and Fukuoka with 257 cases.
According to the Institute, cases of congenital syphilis have been increasing in recent years, with 20 cases reported in 2022. In 2023, six patients were confirmed by early April.
Congenital syphilis is caused by the bacterium Treponema pallidum, which can be passed from mother to child during fetal development or at birth. Up to half of all babies infected with syphilis in the womb die shortly before or after birth.
"There is a possibility that cases of congenital syphilis will increase along with those of syphilis," commented Prof. Satoshi Takahashi, who heads the Japanese Society for Sexually Transmitted Infections, according to local media on May 24, 2023.
"Syphilis is a curable disease, so people should get tested without hesitation if they have worrisome symptoms or concerns."
As of April 11, 2023, the U.S. Centers for Disease Control and Prevention reported 176,713 syphilis cases in 2021 and 2,855 congenital syphilis cases, resulting in 220 stillbirths and infant deaths, a YOY increase of 32%.
Unfortunately, the U.S. Food and Drug Administration has not approved a syphilis vaccine as of May 27, 2023.
The U.S. Centers for Disease Control and Prevention (CDC) today confirmed some US residents returning from Mexico were diagnosed with suspected fungal meningitis infections that have led to severe illness and death.
In a Level 2, Practice Enhanced Precautions advisory issued on May 26, 2023, the CDC stated travelers with these infections had medical or surgical procedures that involved injection of an anesthetic into the area around the spinal column (i.e., epidural) performed at clinics in Matamoros, including River Side Surgical Center and Clinica K-3.
If you had a procedure involving an epidural injection of an anesthetic in Matamoros, Mexico, any time since January 1, 2023, learn what additional steps you should take, says the CDC.
There are millions of fungal species, but only a few hundred of them can make people sick. Fungal meningitis infections are not contagious and are not transmitted from person to person.
Although anyone can get fungal meningitis, people with weakened immune systems are at increased risk.
Certain health conditions, medications, and surgical procedures may weaken the immune system. Symptoms of fungal meningitis infections include fever, headache, stiff neck, nausea, vomiting, confusion, or sensitivity to light.
Fungal meningitis is treated with IV (injected through a vein) and oral medications. The CDC says that treatment length can vary depending on the fungus type.
The Chilean Ministry of Health recently issued a health alert in Arica, Parinacota, Tarapacá, Antofagasta, Atacama, Coquimbo, Valparaíso, and the Metropolitan Region, for the risk of Aedes aegypti mosquitos transmitting viruses such as yellow fever, dengue, chikungunya, zika, and malaria.
The health alert empowers the strengthening of the surveillance system and the adoption of opportune measures for the control of mosquitoes and viruses.
“The Ministry of Health is taking the necessary measures,” Fernando Leanes, representative of the World Health Organization and the Pan American Health Organization in Chile, told CNN Chile on May 4, 2023.
In South America, the Stamaril® yellow fever vaccine is generally available.
Other travel vaccines are listed by Vax-Before-Travel.
